Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.85
+0.06 (0.77%)
Dec 24, 2024, 1:00 PM EST - Market closed
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.43 billion as of December 24, 2024. Its market cap has increased by 56.81% in one year.
Market Cap
2.43B
Enterprise Value
4.98B
1-Year Change
56.81%
Ranking
Category
Stock Price
$7.85
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.43B, a decrease of -57.78%. That is a compound annual growth rate of -11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 2.41B | 29.72% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 2.46B |
| Select Medical Holdings | 2.46B |
| HUTCHMED (China) | 2.45B |
| Dyne Therapeutics | 2.43B |
| Protagonist Therapeutics | 2.42B |
| Tandem Diabetes Care | 2.40B |
| Privia Health Group | 2.39B |
| NewAmsterdam Pharma Company | 2.37B |